Skip to main content
Chembond Material Technologies Limited logo

Chembond Material Technologies Limited — Investor Relations & Filings

Ticker · CHEMBOND ISIN · INE995D01025 LEI · 33580032VMBC7SVBL550 BSE.NS Manufacturing
Open in API
Filings indexed 899 across all filing types
Latest filing 2024-01-25 Regulatory Filings
Country IN India
Listing BSE.NS CHEMBOND

About Chembond Material Technologies Limited

https://www.chembondindia.com/

Chembond Material Technologies Limited specializes in the development, manufacture, and supply of specialty chemicals for surface treatment and industrial applications. The company provides a comprehensive range of metal treatment solutions, including cleaners, degreasers, phosphating chemicals, and chrome-free passivations. Its product portfolio extends to high-performance industrial coatings, wire drawing lubricants, and specialized adhesives designed to enhance durability and corrosion resistance. Serving diverse sectors such as automotive, steel, appliances, and general engineering, the firm focuses on delivering technically advanced and sustainable chemical processes. Through a commitment to research and development, it offers customized formulations that optimize manufacturing efficiency and meet stringent quality standards for surface preparation and protection.

Recent filings

Filing Released Lang Actions
In continuation to our letter bearing ref no. SE/CS/2023-24/58 dated 25th January, 2024, wherein the Financial Results of the Company were given, we would like to inform that the numbers ....
Regulatory Filings
2024-01-25 English
In continuation to our letter bearing ref. no. SE/CS/2023-24/54 dated 17th January, 2024 and pursuant to Regulations 33,30 and other applicable regulations, if any, of the SEBI(LODR), 2015, ....
Regulatory Filings
2024-01-25 English
Financial Result Updates
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement from Chembond Chemicals Limited dated 25th January 2024, reporting the outcome of a Board Meeting where the Board approved the Unaudited Financial Results for the quarter and nine months ended 31st December 2023. It includes the Limited Review Report by the independent auditor, which reviews the interim financial results as per Indian Accounting Standard 34 (Interim Financial Reporting). The document contains extensive financial data, including consolidated financial results, notes, and auditor's review, indicating it is a comprehensive interim financial report rather than a brief announcement or certification. The presence of unaudited consolidated financial results for a quarter and nine months period, along with the auditor's limited review report, aligns with the definition of an Interim / Quarterly Report (IR). It is not an Annual Report (10-K), nor a simple announcement of report publication (RPA), nor a certification (RNS). Therefore, the correct classification is Interim / Quarterly Report (IR). 9M 2024
2024-01-25 English
In continuation to our letter bearing Ref. no. SE/CS/2023-24/54 dated 17th January, 2024, & pursuant to Regulations 33, 30 & other applicable regulations, if any, of the SEBI (LODR), 2015, ....
Regulatory Filings
2024-01-25 English
Board Meeting — CHEMBOND CHEMICALS LTD has informed the Exchange about Board Meeting to be held on 25-Jan-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for th…
Regulatory Filings
2024-01-17 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about an upcoming Board of Directors meeting scheduled to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2023. It references compliance with SEBI regulations and insider trading rules. The document does not contain the financial results themselves but informs about the meeting where these results will be approved. The document length is short (2091 characters) and serves as an announcement rather than a report. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit into other specific categories like Interim Report or Earnings Release, which would require actual financial data or results.
2024-01-17 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.